Skip to main content
Premium Trial:

Request an Annual Quote

Everist Genomics Forms Joint Venture Targeting Indian Market

NEW YORK (GenomeWeb News) – Everist Genomics today announced a joint venture with Manipal Group to establish a business presence in India.

The joint venture will market Everist's diagnostic, prognostic, and therapeutic solutions through Manipal's healthcare network in India, which includes 15 hospitals, nine primary care clinics, and 55 community health centers. Additionally, the deal leverages Manipal's background in medical products, commercially viable infrastructure, and capabilities in the region, Everist said.

The joint venture will commercialize Everist's companion diagnostics and prognostic portfolio for cancer, a combination of four molecular assays to guide physicians treating oncology patients. The portfolio includes testing for colorectal and uterine cancer and will be expanded to include other indications.

The joint venture also will commercialize Everist's cardiovascular diagnostics and monitoring products.

Manipal, based in Bangalore, India, is one of the three largest healthcare firms in India, Everist said.

The partnership is anticipated to generate more than $100 million in revenues during the next 36 months, accelerating Everist's growth and the creation of high-tech jobs at the firm in areas such as research and development, regulatory affairs, and manufacturing, according to Everist Executive Vice Chairman Alex Charlton.

The Ann Arbor, Mich.-based company added that it plans to expand its presence into other geographies including China, Japan, and Brazil.

"Our partnership with Manipal provides a successful model to penetrate high-growth markets with disruptive technologies," Charlton said in a statement, adding that Everist is evaluating other markets for similar partnerships.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.